The Future of Medicines in Europe

A panel discussion

On Wednesday 26th April the European Commission published its legislative proposal for the pharmaceutical review, the first in two decades. Their strategy is set to bring about significant changes to the EU biopharmaceutical and healthcare sector. The legislative measures included in the strategy will present the sector with both challenges and opportunities in the areas of innovation, competitiveness, access to medicines, shortages and intellectual property.

Hear from our panel of experts on the implications of this strategy for the industry in Europe and in Ireland.

To view this event please click here.